Medvirsta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 28,300 | 4,729 | 378,097 | 1,269,006 | 1,945,952 | 904,022 | 845,816 | 685,353 |
| Profit before tax | - | - | - | 80,492 | 125,114 | 160,268 | 38,956 | -24,620 |
| Net profit | -4,979 | 3,221 | 18,820 | 68,010 | 106,322 | 136,228 | 32,986 | -24,620 |
| Equity | 56 | 3,141 | 29,791 | 97,234 | 203,557 | 339,784 | 372,771 | 348,150 |
| Liabilities | 11,601 | 7,874 | 54,938 | 170,799 | 497,171 | 346,338 | 364,341 | 794,136 |
| Non-current assets | 0 | 0 | 2,750 | 28,603 | 142,689 | 252,452 | 279,781 | 252,761 |
| Current assets | 11,657 | 11,015 | 81,979 | 239,430 | 558,039 | 433,670 | 457,331 | 889,525 |
| Total assets | 11,657 | 11,015 | 84,729 | 268,033 | 700,728 | 686,122 | 737,112 | 1,142,286 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 40,183 | 16,717 | 2,168 |
| Social insurance contributions | - | - | - | - | - | 31,620 | 22,907 | 13,037 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +77.8% | -83.3% | +7895.3% | +235.6% | +53.3% | -53.5% | -6.4% | -19.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -42.7% | 29.2% | 22.2% | 25.4% | 15.2% | 19.9% | 4.5% | -2.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -8891.1% | 102.5% | 63.2% | 69.9% | 52.2% | 40.1% | 8.8% | -7.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -17.6% | 68.1% | 5.0% | 5.4% | 5.5% | 15.1% | 3.9% | -3.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 6.3% | 6.4% | 17.7% | 4.6% | -3.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 207.2 | 2.5 | 1.8 | 1.8 | 2.4 | 1.0 | 1.0 | 2.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 28,300 | 4,729 | 189,049 | 34,767 | 55,599 | 48,430 | 79,295 | 105,439 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medvirsta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-18 | 2025-03-09 | 0.01 |
| 2025-01-16 | 2025-02-13 | 0.02 |
| 2025-01-02 | 2025-01-12 | 0.02 |
| 2024-12-22 | 2024-12-31 | 0.02 |
| 2024-12-17 | 2024-12-20 | 0.02 |
| 2024-11-18 | 2024-12-09 | 0.02 |
| 2024-10-16 | 2024-11-11 | 0.03 |
| 2024-05-16 | 2024-05-21 | 1754.45 |
| 2023-10-26 | 2023-10-30 | 2.93 |
| 2023-10-17 | 2023-10-19 | 2.93 |
| 2023-10-12 | 2023-10-12 | 2.93 |
| 2023-09-28 | 2023-10-09 | 407.16 |
| 2023-08-17 | 2023-09-07 | 0.02 |
| 2023-07-26 | 2023-08-08 | 17.42 |
| 2023-07-24 | 2023-07-25 | 17.77 |
| 2023-06-16 | 2023-06-26 | 2903.50 |
| 2023-04-26 | 2023-04-26 | 683.30 |
| 2023-04-25 | 2023-04-25 | 2636.85 |
| 2023-04-18 | 2023-04-24 | 1953.55 |
| 2022-12-16 | 2023-01-02 | 11.65 |
| 2022-02-02 | 2022-02-06 | 1.12 |
| 2022-01-27 | 2022-02-01 | 1.06 |
Medvirsta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-20 | 2026-05-20 | 284.83 |
| 2026-05-15 | 2026-05-19 | 283.31 |
| 2026-04-17 | 2026-04-28 | 564.89 |
| 2025-04-24 | 2025-04-25 | 2.55 |
| 2025-04-18 | 2025-04-23 | 551.89 |
| 2025-04-17 | 2025-04-17 | 551.74 |
| 2025-04-16 | 2025-04-16 | 549.34 |
| 2025-04-03 | 2025-04-15 | 1.63 |
| 2025-03-28 | 2025-03-31 | 6322.91 |
| 2025-03-27 | 2025-03-27 | 849.43 |
| 2025-03-26 | 2025-03-26 | 6319.81 |
| 2025-03-23 | 2025-03-25 | 16099.28 |
| 2025-03-22 | 2025-03-22 | 16090.16 |
| 2025-03-20 | 2025-03-21 | 10077.52 |
| 2025-03-19 | 2025-03-19 | 9793.63 |
| 2024-12-22 | 2024-12-28 | 1.7 |
| 2024-12-21 | 2024-12-21 | 3.59 |
| 2024-12-20 | 2024-12-20 | 269.98 |
| 2024-12-19 | 2024-12-19 | 269.84 |
| 2024-12-18 | 2024-12-18 | 268.28 |
| 2024-12-17 | 2024-12-17 | 268.21 |
| 2024-10-09 | 2024-10-09 | 2.15 |
| 2024-10-01 | 2024-10-08 | 1383.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medvirsta, UAB (code 300610953) is a Private Limited Liability Company operating in floor and wall covering. In 2025, revenue amounted to EUR 685.4K, down from EUR 845.8K in 2024 and EUR 904.0K in 2023, showing a continued decline over the three-year period. Net profit also weakened from EUR 136.2K in 2023 to EUR 33.0K in 2024 and turned into a loss of EUR 24.6K in 2025. The profit margin fell from 15.1% in 2023 to 3.9% in 2024 and -3.6% in 2025. At the same time, total assets increased to EUR 1.14M in 2025 from EUR 737.1K a year earlier, while equity stood at EUR 348.1K and liabilities at EUR 794.1K. The equity ratio was 30.5% and debt-to-equity reached 2.28. Asset turnover was 0.60x, ROE was -7.1%, and ROA was -2.2%. Revenue per employee was EUR 114.2K, while profit per employee was EUR -4.1K.